ATE457030T1 - Hpv-impfstoff, enthaltend peptide aus host-cell- proteinen - Google Patents

Hpv-impfstoff, enthaltend peptide aus host-cell- proteinen

Info

Publication number
ATE457030T1
ATE457030T1 AT05763123T AT05763123T ATE457030T1 AT E457030 T1 ATE457030 T1 AT E457030T1 AT 05763123 T AT05763123 T AT 05763123T AT 05763123 T AT05763123 T AT 05763123T AT E457030 T1 ATE457030 T1 AT E457030T1
Authority
AT
Austria
Prior art keywords
hpv
host cell
cell proteins
vaccine
peptides
Prior art date
Application number
AT05763123T
Other languages
English (en)
Inventor
Stephen Tze Kwung Man
Original Assignee
Univ Cardiff
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Cardiff filed Critical Univ Cardiff
Application granted granted Critical
Publication of ATE457030T1 publication Critical patent/ATE457030T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Magnetic Heads (AREA)
  • Saccharide Compounds (AREA)
  • Liquid Crystal (AREA)
AT05763123T 2004-08-05 2005-07-27 Hpv-impfstoff, enthaltend peptide aus host-cell- proteinen ATE457030T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0417430.6A GB0417430D0 (en) 2004-08-05 2004-08-05 A novel HPV vaccine comprising peptides from host cell proteins
PCT/GB2005/002962 WO2006013336A1 (en) 2004-08-05 2005-07-27 Hpv vaccine comprising peptides from host cell proteins

Publications (1)

Publication Number Publication Date
ATE457030T1 true ATE457030T1 (de) 2010-02-15

Family

ID=32982559

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05763123T ATE457030T1 (de) 2004-08-05 2005-07-27 Hpv-impfstoff, enthaltend peptide aus host-cell- proteinen

Country Status (11)

Country Link
US (2) US7538183B2 (de)
EP (1) EP1773876B1 (de)
JP (1) JP2008508873A (de)
CN (1) CN101027317B (de)
AT (1) ATE457030T1 (de)
AU (1) AU2005268646B2 (de)
CA (1) CA2575610C (de)
DE (1) DE602005019238D1 (de)
GB (1) GB0417430D0 (de)
HK (1) HK1097279A1 (de)
WO (1) WO2006013336A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI441648B (zh) 2007-01-03 2014-06-21 Oncotherapy Science Inc Ｆｏｘｐ３胜肽疫苗
US8877206B2 (en) 2007-03-22 2014-11-04 Pds Biotechnology Corporation Stimulation of an immune response by cationic lipids
CN102234688A (zh) * 2010-04-30 2011-11-09 北京心意圆成生物科技有限公司 一种哺乳动物细胞dna快速定量检测方法
MX2016003957A (es) 2013-09-25 2017-02-02 Cytomx Therapeutics Inc Substratos de metaloproteinasas de matriz y otras porciones escindibles y metodos para usar los mismos.
JP6835586B2 (ja) 2014-01-31 2021-02-24 シトムクス セラピューティクス，インコーポレイティド マトリプターゼ及びｕ‐プラスミノーゲン活性化因子の基質及び他の切断可能部分、並びにその使用方法
CN107001430A (zh) 2014-10-24 2017-08-01 哈普威克斯有限责任公司 癌症和皮肤病变治疗
US10799574B2 (en) 2014-10-24 2020-10-13 Hpvvax. Llc Method and composition for treating cancer or skin lesion using a vaccine
MA41374A (fr) 2015-01-20 2017-11-28 Cytomx Therapeutics Inc Substrats clivables par métalloprotéase matricielle et clivables par sérine protéase et procédés d'utilisation de ceux-ci
JP7115803B2 (ja) 2016-06-20 2022-08-09 アイエスエー ファーマシューティカルズ ビー．ヴイ． ペプチドワクチン製剤
CN110035765B (zh) * 2016-10-05 2024-04-02 Pds生物科技公司 新型hpv16非hla限制性t细胞疫苗、组合物及其使用方法
EP4238982A1 (de) * 2020-10-28 2023-09-06 National University Corporation Hokkaido University Antitumorpeptid und verwendung davon

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6183746B1 (en) * 1997-10-09 2001-02-06 Zycos Inc. Immunogenic peptides from the HPV E7 protein
DE19859486A1 (de) * 1998-12-22 2000-07-06 Razvan Tudor Radulescu Peptide mit besonderen antiproliferativen Eigenschaften
US6440696B1 (en) * 1999-07-28 2002-08-27 New England Medical Center E6 targeted protein (E6TP1)
GB0206360D0 (en) * 2002-03-18 2002-05-01 Glaxosmithkline Biolog Sa Viral antigens
FR2839072A1 (fr) * 2002-04-24 2003-10-31 Neovacs Produit d'expression d'un adn codant une proteine e7 mutee de hpv-16, composition immunogene contenant ledit produit d'expression et son procede de preparation
US20050272038A1 (en) * 2002-07-29 2005-12-08 Ruediger Ridder Compositions and methods for diagnosis and therapy of cancers
US7223408B2 (en) * 2002-10-03 2007-05-29 Wyeth Holdings Corporation Human papillomavirus polypeptides and immunogenic compositions

Also Published As

Publication number Publication date
WO2006013336A1 (en) 2006-02-09
US20070218074A1 (en) 2007-09-20
AU2005268646B2 (en) 2011-01-06
US20090232842A1 (en) 2009-09-17
AU2005268646A1 (en) 2006-02-09
CA2575610C (en) 2014-02-11
CA2575610A1 (en) 2006-02-09
HK1097279A1 (en) 2007-06-22
AU2005268646A2 (en) 2006-02-09
CN101027317A (zh) 2007-08-29
EP1773876A1 (de) 2007-04-18
WO2006013336A9 (en) 2007-03-29
DE602005019238D1 (de) 2010-03-25
CN101027317B (zh) 2013-01-30
JP2008508873A (ja) 2008-03-27
GB0417430D0 (en) 2004-09-08
US7538183B2 (en) 2009-05-26
EP1773876B1 (de) 2010-02-03

Similar Documents

Publication Publication Date Title
ATE457030T1 (de) Hpv-impfstoff, enthaltend peptide aus host-cell- proteinen
NO2018010I1 (no) HPV 31 L1 protein
AR077396A2 (es) EXPRESIoN OPTIMIZADA DE LA PROTEíNA DE LA CÁPSIDE L1 DEL VIRUS DE PAPILOMA HUMANO VPH45 EN LEVADURAS
MX2020010035A (es) Receptores de celulas t anti-papilomavirus 16 e7 humano.
ATE485305T1 (de) Immunogene peptide und verwendungsverfahren dafür
EP3584251A3 (de) Hpv-epitope als ziel für zervikale tumoren infiltrierende t-zellen zur verwendung bei impfstoffen
TR201908199T4 (tr) HPV'ye karşı aşılar.
WO2010149752A3 (en) Novel human papillomavirus (hpv) protein constructs and their use in the prevention of hpv disease
TW200519203A (en) Optimized expression of HPV 58 L1 in yeast
DK1968632T3 (da) Forbedret influenzavaccine
HK1125051A1 (en) Virus-like particles as vaccines for paramyxovirus
MXPA05005051A (es) Vacuna de vector adenoviral.
NZ745324A (en) Vaccines and vaccine components for inhibition of microbial cells
NZ730802A (en) Therapeutic hpv16 vaccines
EP2589604A4 (de) Verkürztes l1-protein des humanen papillomavirus vom typ 52
WO2010079991A3 (ko) 안정적인 항시적 고발현 자궁경부암 치료백신용 벡터 및 그에 의해 형질전환된 재조합 유산균
NZ609916A (en) Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
NZ594198A (en) Neil3 peptides and vaccines including the same
PT1290160E (pt) Polipeptideos pellino humanos
NZ606949A (en) Human papillomavirus e7 antigen compositions and uses thereof
ATE457349T1 (de) Granzyme b als ein hsp70/hsp70 peptid-abhängige apoptoseauslöser in tumorzellen
UA98254C2 (ru) мукозальная вакцина для иммунотерапии заболеваний, обусловленных вирусами папилломы человека
EA201700162A1 (ru) Оптимизированный гибридный белок вируса папилломы человека для использования в качестве антигена в терапевтической вакцине
PL1716169T3 (pl) Podjednostkowe szczepionki przeciwko Ornithobacterium rhinotracheale
TH130273A (th) เซลล์เพนนิเทรติงเพพไทด์ และการใช้มันเชื่อมกับชีวโมเลกุลที่มีฤทธิ์การรักษา

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties